Stock Price
2.48
Daily Change
-0.01 -0.40%
Monthly
-10.14%
Yearly
-17.88%
Q1 Forecast
2.48

Mesoblast reported $1.28B in Ordinary Share Capital for its fiscal semester ending in June of 2025.





Ordinary Share Capital Change Date
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Cochlear AUD 1.18B 19.2M Dec/2024
CSL USD 576M 19M Dec/2024
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Ramsay Health Care AUD 2.27B 19.6M Dec/2024
Sonic Healthcare AUD 4.15B 467K Dec/2024
Starpharma Holdings AUD 240.75M 0 Dec/2024
Telix Pharmaceuticals AUD 587.41M 141.14M Jun/2024